Smith & Nephew plc

Smith & Nephew is a global medical devices company that develops, manufactures, and markets products across three main segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. In Orthopaedics, it offers knee and hip implants for replacement and revision surgeries, as well as trauma products for fracture stabilization and deformity correction. The Sports Medicine & ENT segment provides minimally invasive surgical instruments, implants, and visualization technologies for treating soft tissue injuries and degenerative conditions of joints, plus ear, nose, and throat solutions. Advanced Wound Management includes wound care products for acute and chronic wounds, such as leg ulcers, diabetic ulcers, burns, and post-operative wounds, along with bioactive technologies and regenerative medicine products like skin substitutes and bone graft materials.

Smith & Nephew plc is listed on the New York Stock Exchange (NYSE) under the ticker symbol SNN. The company trades in US Dollars (USD), even though it is headquartered in the United Kingdom. This listing on the NYSE provides US investors with direct access to the company's shares in their local currency, while the company also has a primary listing on the London Stock Exchange under the ticker SN.

Smith & Nephew operates in the Healthcare sector, specifically within the Medical Devices industry. As a medical devices company, it focuses on developing and manufacturing products used in surgical procedures, wound management, and orthopedic treatments. The company's portfolio includes implants, instruments, and advanced wound care technologies that are used by healthcare professionals worldwide. Being in the medical devices industry means Smith & Nephew is subject to regulatory approvals, clinical research, and innovation cycles typical of the healthcare sector.

Smith & Nephew is headquartered in the United Kingdom, but it operates globally. The company's products are sold in markets around the world, with a significant presence in the US region, as indicated by its NYSE listing and USD trading currency. Its global reach includes serving hospitals, clinics, and healthcare providers across multiple continents. The company's three business segments—Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management—address a wide range of medical needs, from joint replacement and sports injuries to chronic wound care, making its products relevant in both developed and emerging healthcare markets.

Smith & Nephew generates revenue by selling medical devices and services across three main segments. The Orthopaedics segment contributes through sales of knee and hip implants, trauma products, and reconstruction devices used in joint replacement and fracture surgeries. The Sports Medicine & ENT segment earns revenue from minimally invasive surgical instruments, implants, and visualization technologies for joint repair and ENT procedures. The Advanced Wound Management segment sells wound care products, including dressings, bioactives, and regenerative medicine products like skin substitutes and bone graft materials. The company's diversified portfolio allows it to capture revenue from multiple high-growth areas within the medical device industry.